Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Interim Order Respecting Epinephrine Auto-injectors Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment; Therefore, the Minister of Health, pursuant to subsection…
Patient Information — Auvi-Q® (epinephrine injection) Auto-Injector For Allergic Emergencies (Anaphylaxis) AUVI-Q® (epinephrine injection) Auto-Injector For allergic emergencies (anaphylaxis) Read this Patient Information Leaflet before you have to use AUVI-Q and each time you…
Notice of Amendment: List of Opioids (Part A): Buprenorphine and Methadone Date: October 1, 2018 The purpose of this Notice of Amendment is to notify stakeholders that Health Canada has amended Part A of the List of Opioids . A qualifier has been added to the list to exempt…
Notice to Stakeholders – Opioid warning sticker and patient information handout requirements come into force on October 23, 2018 October 1 st , 2018 Our reference number: 18-113393-207 Canada's Food and Drug Regulations were recently amended to require that a warning sticker and…
Notice - Health Canada's efforts to support innovative human therapeutic products to combat antimicrobial resistance (AMR) November 15, 2018 Our File number: 18-118504-727 The Issue Antimicrobial resistant (AMR) infections are becoming more frequent and increasingly difficult to…
Excellence en recherche aux IRSC Sur cette page Message de Rhonda Kropp, vice-présidente à la recherche — Systèmes de santé apprenants Excellence en recherche : état des lieux Excellence en recherche : le nœud du problème Nouveau cadre des IRSC pour l'excellence de la recherche…
Notice: Release of the Draft Guidance Document: Regulatory Requirements for Drug Identification Numbers (DINs) January 25, 2019 Our file number: 18-122097-698 The above referenced draft guidance was released by Health Canada for consultation and is being posted on the website for…
Draft Guidance Document: Public or Canadian Armed Forces Health Emergencies - Drugs for Immediate Use or Stockpiling This guidance document is being distributed for comment purposes only. Draft Date: 2019/05/10 ( PDF version ) Foreword Guidance documents are meant to provide…
Le sexe et le genre dans la recherche en santé Il est clairement démontré que les différences biologiques et sociales entre les femmes, les hommes, les filles, les garçons et les personnes de diverses identités de genre contribuent aux différences sur le plan de la santé. Le sexe…
Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials 1) Context This statement provides guidance to clinical trial applicants about the investigational use of marketed drugs within clinical trials in Canada. It will serve as interim…
Early release: coverage and features are still expanding.
